Comparing two antiviral medications to prevent viral infections after kidney transplant

After a kidney transplant, your immune system is weakened by medications that help prevent rejection, which puts you at risk for two common viruses: CMV and EBV. This study is testing whether a medication called valacyclovir works as well as the standard medication (valganciclovir) at preventing these viral infections. The medication aims to keep these viruses from becoming active and causing serious problems.

The standard medication used to prevent these viral infections can cause serious side effects like low blood cell counts and kidney damage. This study wants to know if the new treatment might work just as well but with fewer side effects and at a lower cost.